Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19643 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Anna L Godfrey und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Hauptthemen laut MEDLINE: Calreticulin, Janus Kinase 2, Mutation, Receptors, Thrombopoietin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Cancer Research UK Oxford Centre, Oxford Hospitals Charity, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC).
Abstract (Originalsprache)
Diagnosis of essential thrombocythaemia (ET) is challenging in patients lacking JAK2 / CALR / MPL mutations. In a retrospective evaluation of 320 patients with ‘triple‐negative thrombocytosis’, we assessed utility of bone marrow histology (90.9% of patients) and myeloid gene panel (MGP, 55.6%). Supportive histology (‘myeloproliferative neoplasm‐definite/probable’, 36.8%) was associated with higher platelet counts and varied between centres. 14.6% MGP revealed significant variants: 3.4% JAK2 / CALR / MPL and 11.2% other myeloid genes. Final clinical diagnosis was strongly predicted by histology, not MGP. 23.7% received cytoreduction (17.6% under 60 years). Real‐world ‘triple‐negative’ ET diagnosis currently depends heavily on histology; we advocate caution in MGP‐negative cases and that specific guidelines are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
- NIHR Biomedical Research Centre and MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
- Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
- Department of Haematology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK.
- Department of Histopathology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Department of Haematology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
ORCID-Profile: Anna L Godfrey, Nikolaos Sousos, Alesia Khan, Andrew J Wilson, Daniel Royston, Claire N Harrison, Adam J Mead
Förderung
- Cancer Research UK Oxford Centre
- Oxford Hospitals Charity
- National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC)
- National Institute for Health and Care Research
Zitieren
APA
Godfrey, A. L., Sousos, N., Frewin, R., Prahladan, M., Green, A. C., McGregor, A., Khan, A., Milne, K., Amin, F., Torre, E., Gudgin, E. J., Lambert, J., Wilson, A. J., Royston, D., Harrison, C. N., & Mead, A. J. (2024). Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice. British Journal of Haematology. https://doi.org/10.1111/bjh.19643
Vancouver
Godfrey AL, Sousos N, Frewin R, Prahladan M, Green AC, McGregor A, et al. Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice. British Journal of Haematology. 2024. doi:10.1111/bjh.19643
BibTeX
@article{Godfrey2024,
author = {Godfrey, Anna L and Sousos, Nikolaos and Frewin, Rebecca and Prahladan, Mahesh and Green, Anna C and McGregor, Andrew and Khan, Alesia and Milne, Kate and Amin, Faisal and Torre, Elena and Gudgin, Emma J and Lambert, Jonathan and Wilson, Andrew J and Royston, Daniel and Harrison, Claire N and Mead, Adam J},
title = {Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19643}
}
EUVIMED